EMA/審査関係の更新通知(2023年12月18日付)
2023年12/18付でEMAから審査関係の更新通知が発出されています。
これら通知類は「Regulatory and procedural guideline」などと合せて時折更新されます。
関係者にあっては、「What's New?」ウェブサイト(下記URL)かあるいは個々のタイトルからリンク先をあたってください。
- 「What's New?」ウェブサイト
- 個々の通知類(審査関係のため安全性に関わるものも加えています)
・Pre-authorisation guidance
https://www.ema.europa.eu/en/human-regulatory-overview/marketing-authorisation/pre-authorisation-guidance・Type-IA variations: questions and answers
https://www.ema.europa.eu/en/type-ia-variations-questions-and-answers・Risk management plans (RMP) in post-authorisation phase: questions and answers
https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/risk-management-plans-rmp-post-authorisation-phase-questions-and-answers・European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure_en.pdf・European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-post-authorisation-procedural-advice-users-centralised-procedure-document-track-changes_en.pdf・European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure_en.pdf・European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-pre-authorisation-procedural-advice-users-centralised-procedure-document-tracked-changes_en.pdf
コメント
/
/
/
この記事へのコメントはありません。
コメント